INNERVATE RADIOPHARMACEUTICALS Trademark
Trademark Overview
On Monday, March 3, 2025, a trademark application was filed for INNERVATE RADIOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the INNERVATE RADIOPHARMACEUTICALS trademark a serial number of 99064464. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, January 12, 2026. This trademark is owned by INNERVATE RADIOPHARMACEUTICALS LLC. The INNERVATE RADIOPHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Scientific research; Scientific research in the field of pharmacy; Research on the subject of pharmaceuticals; Medical research; Research and development services of new pharmaceutical products; Providing scientific information in the field of biochemistry, biotechnology and clinical trials; Scientific research consulting in the field of biotechnology, pharmaceutical research and development, and genetic science in relation to radiopharmaceuticals and cancer
General Information
| Serial Number | 99064464 |
| Word Mark | INNERVATE RADIOPHARMACEUTICALS |
| Filing Date | Monday, March 3, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, January 12, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 3, 2026 |
Trademark Statements
| Goods and Services | Scientific research; Scientific research in the field of pharmacy; Research on the subject of pharmaceuticals; Medical research; Research and development services of new pharmaceutical products; Providing scientific information in the field of biochemistry, biotechnology and clinical trials; Scientific research consulting in the field of biotechnology, pharmaceutical research and development, and genetic science in relation to radiopharmaceuticals and cancer |
| NOT AVAILABLE | "RADIOPHARMACEUTICALS" |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 4, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Friday, November 30, 2018 |
| First Use In Commerce Date | Friday, November 30, 2018 |
Trademark Owner History
| Party Name | INNERVATE RADIOPHARMACEUTICALS LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Englewood, NJ 07631 |
Trademark Events
| Event Date | Event Description |
| Monday, March 3, 2025 | NEW APPLICATION ENTERED |
| Monday, March 3, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, July 23, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 5, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, August 5, 2025 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Tuesday, August 5, 2025 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
| Tuesday, August 5, 2025 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Tuesday, August 5, 2025 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Monday, November 3, 2025 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, November 3, 2025 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, January 6, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 6, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 6, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 7, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
